Pfizer Inc.
PFE | NYSE
$30.52
+$0.57 (+1.90%)
At close: Oct 30, 2026, 4:00 PM ET
$30.36
-$0.16 (-0.52%)
Pre-market:
Nov 2, 2026, 4:04 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 18.31 | 18.68 | 76.67 | 9.16 | 14.93 | 22.33 |
PEG Ratio | -4.33 | 0.07 | -0.82 | 0.22 | 0.11 | -0.51 |
PS Ratio | 2.26 | 2.36 | 2.73 | 2.86 | 4.07 | 4.91 |
PB Ratio | 1.64 | 1.70 | 1.83 | 3 | 4.28 | 3.23 |
P/FCF Ratio | 15.59 | 15.28 | 33.90 | 11.04 | 11.07 | 17.61 |
P/OCF Ratio | 12.09 | 11.79 | 18.67 | 9.82 | 10.15 | 14.20 |
OCF/S Ratio | 18.70 | 20.03 | 14.61 | 29.17 | 40.08 | 34.58 |
Debt / Equity Ratio | 0.78 | 0.76 | 0.80 | 0.36 | 0.48 | 0.61 |
Quick Ratio | 0.87 | 0.92 | 0.69 | 1 | 1.19 | 1.04 |
Current Ratio | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 | 1.35 |
Asset Turnover | 0.30 | 0.30 | 0.26 | 0.51 | 0.45 | 0.27 |
Interest Coverage | 5.78 | 5.33 | 2.40 | 30.33 | 16.11 | 6.27 |
Return on Equity | 8.99% | 9.09% | 2.40% | 32.79% | 28.69% | 14.48% |
Return on Assets | 3.73% | 3.76% | 0.94% | 15.90% | 12.20% | 5.94% |
Return on Invested Capital | 8.84% | 9.28% | 2.80% | 21.49% | 13.62% | 6.57% |
Dividend Yield | 6.91% | 6.33% | 5.69% | 3.13% | 2.64% | 4.13% |
Payout Ratio | 125.75% | 118.60% | 433.52% | 28.64% | 39.41% | 92.15% |
FCF Payout Ratio | 107.66% | 106.18% | 216.66% | 35.70% | 30.43% | 77.75% |
Gross Profit Margin | 70.33% | 65.77% | 50.95% | 61.89% | 57.67% | 71.74% |
Net Profit Margin | 12.42% | 12.60% | 3.58% | 31.26% | 27.25% | 21.99% |
Pretax Profit Margin | 12.02% | 12.61% | 1.78% | 34.61% | 29.91% | 16.89% |
Operating Profit Margin | 24.67% | 25.91% | 8.89% | 37.43% | 25.58% | 21.81% |
FCF Margin | 14.50% | 15.46% | 8.05% | 25.95% | 36.74% | 27.88% |
EBITDA Margin | 24.12% | 28.49% | 16.05% | 40.90% | 37.88% | 31.62% |
Add to Watchlist
Select watchlists to add or remove PFE